IPO registrations (S-1, F-1) · Registrants
EXACT SCIENCES CORP
- SEC CIK
- 1124140 · filings on EDGAR ↗
- Name on the registration
- EXACT CORP
- Former names
- EXACT CORP (2000–2001)
- Registration
- Form S-1, first filed 2000-10-27, last 2001-01-30; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2001-01-31
- Industry (SIC)
- Services-Medical Laboratories 8071
- Business address
- 5505 ENDEAVOR LANE, Madison, WI 53719
- EIN
- 20-0478229
- EDGAR entity type
- operating
- Insiders and CEO pay
- EXACT SCIENCES CORP on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2001-01-30)
- Final price
- $14.00 per share, within the range (424B4 filed 2001-01-31, an initial public offering)
- Shares sold
- 4,000,000
- Gross proceeds
- $56,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol EXAS
- Lead underwriters
- Merrill Lynch
- Syndicate
- CIBC World Markets (695,000); Thomas Weisel Partners (695,000); Credit Suisse (50,000); RBC Capital Markets (50,000); Prudential Securities (50,000); Robertson Stephens (50,000); Cowen (50,000); UBS (50,000); Adams Harkness (20,000); Dominick & Dominick LLC (20,000); Gerard Klauer Mattison & Co., Inc (20,000); Josephthal & Co. Inc (20,000); Needham & Company (20,000); Stephens (20,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Exact Sciences Corporation Fuzzy (name and state)
- Business registration: Exact Sciences Corporation Fuzzy (name and state)
- Business registration: Exact Sciences Corporation Fuzzy (name and state)
- Business registration: Exact Sciences Corporation Fuzzy (name and state)
- Business registration: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Business registration: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Business registration: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Business registration: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Business registration: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Federal award recipient: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- Lobbying client: EXACT SCIENCES CORPORATION Fuzzy (name and state)
- SEC filer: EXACT SCIENCES CORP EXACT (CIK (EXACT))
- Person page: Daniel J Levangie Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: James P Connelly Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Thomas D Carey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-10-27 | S-1 | S-1 (registration) | EXACT CORP | 0000912057-00-046284 ↗ |
| 2000-12-04 | S-1/A | S-1/A (amendment) | EXACT CORP | 0000912057-00-052154 ↗ |
| 2000-12-07 | S-1/A | S-1/A (amendment) | EXACT CORP | 0000912057-00-052495 ↗ |
| 2000-12-26 | S-1/A | S-1/A (amendment) | EXACT CORP | 0000912057-00-054714 ↗ |
| 2001-01-08 | S-1/A | S-1/A (amendment) | EXACT CORP | 0000912057-01-000498 ↗ |
| 2001-01-30 | S-1/A | S-1/A (amendment) | EXACT CORP | 0000912057-01-003283 ↗ |
| 2001-01-31 | 424B4 | 424B4 (final prospectus) | EXACT CORP | 0000912057-01-003662 ↗ |
| 2001-01-31 | 424B4 | 424B4 (final prospectus) | EXACT CORP | 0000912057-01-003666 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2001-01-30 | S-1/A | registration statement | $14.00–$16.00 | 4,000,000 | - | Nasdaq EXAS | 7 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 4, cover names 3 | document ↗ | |
| 2001-01-31 | 424B4 | final prospectus | $14.00 | 4,000,000 | $56,000,000 | Nasdaq EXAS | 15 | primary document; price sentence, shares headline, proceeds table, underwriting table 14, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Carelli Charles R Jr | Officer | Prin. Acct. Off. & Corp. Ctlr.; SVP, CFO,Treasurer & Secretary; SVR, CFO, Treasurer & Secretar; Vice President Finance; Vice President, Finance | 9 | 2006–2009 | |
| HARDISON DON M | Director,Officer | President, CEO and Director | 4 | 2006–2007 | |
| LUBER JEFFREY R | Director,Officer; Officer | General Counsel; President; President and CEO; SVP, CFO, & General Counsel; VP, CFO, Treas, Gen Couns, Sec | 9 | 2006–2009 | |
| SHUBER ANTHONY P | Officer | Chief Tech Officer & Sen. V.P. | 1 | 2006 | |
| WILCOX HARRY W | Officer | Senior Vice President and CFO | 1 | 2006 | |
| CRAWFORD SALLY | Director | 13 | 2006–2014 | ||
| KANIA EDWIN M JR | Director | 5 | 2006–2009 | ||
| MCGILLICUDY CORNELIUS III | Director | 5 | 2006–2009 | ||
| WILLSEY LANCE | Director | 5 | 2006–2009 | ||
| ZENNER PATRICK J | Director; Director,Officer | Exec. Chairman & Interim CEO | 6 | 2006–2009 | |
| Nikka David | Officer | Chief Operating Officer | 1 | 2007 | |
| Singer Michael E | Director | 2 | 2008 | ||
| ARORA MANEESH | Director,Officer; Officer | COO; COO and CFO; Senior VP and CFO; Sr. VP & CFO; Vice President | 42 | 2009–2018 | |
| Conroy Kevin T | Director,Officer | President and CEO; President & CEO; Vice President | 117 | 2009–2026 | |
| Connelly James P | Director | 11 | 2009–2013 | person page Fuzzy | |
| Napier Katherine S | Director | 36 | 2009–2026 | ||
| LIDGARD GRAHAM PETER | Director; Officer | Chief Science Officer; Sr. VP, Chief Science Officer; SVP, Chief Scientific Officer | 61 | 2009–2021 | |
| Berger Barry M | Officer | Chief Medical Officer; SVP, Chief Medical Officer | 3 | 2009–2010 | |
| LEVANGIE DANIEL J | Director | 24 | 2010–2025 | person page Fuzzy | |
| Sterling Lionel | Director | 14 | 2010–2017 | ||
| THOMPSON DAVID | Director | 16 | 2010–2019 | ||
| Krayacich John M | Officer | SVP, Sales and Marketing | 2 | 2011 | |
| Stoltenberg Laura S | Officer | Chief Commercial Officer | 4 | 2012–2013 | |
| Carey Thomas D. | Director | 18 | 2013–2021 | person page Fuzzy | |
| Megan William J. | Officer | SVP, Finance; SVP, Finance & PFO | 7 | 2013–2015 | |
| Doyle James Edward | Director | 33 | 2014–2026 | ||
| COWARD D SCOTT | Director; Officer | Chief Administrative Officer; Chief Legal Officer; SVP and General Counsel | 57 | 2015–2026 | |
| WYZGA MICHAEL S | Director | 13 | 2015–2021 | ||
| BAKEWELL JOHN K | Officer | Chief Financial Officer | 2 | 2016 | |
| Fallon John A. | Director | 6 | 2016–2018 | ||
| Elliott Jeffrey Thomas | Officer | Chief Financial Officer | 45 | 2016–2024 | |
| Casdin Eli | Director | 6 | 2017–2020 | ||
| Stenhouse Mark | Officer | President, Cologuard | 8 | 2018–2020 | |
| Johnson Scott C. | Officer | SVP - Research and Development | 4 | 2019 | |
| Sebelius Kathleen | Director | 10 | 2019–2024 | ||
| Hooker Ana | Officer | SVP, Operations | 1 | 2019 | |
| Jacquet Pierre | Director | 7 | 2019–2023 | ||
| Slavitt Andrew M | Director | 3 | 2019–2020 | ||
| Cole G Bradley | Officer | General Manager - Diagnostics | 6 | 2019–2020 | |
| Hoof Torsten | Officer | General Manager, International | 6 | 2019–2020 | |
| ORVILLE JACOB A | Officer | EVP, GM, Screening; General Manager, New Ventures; General Manager, Screening | 32 | 2019–2026 | |
| Paulsen Gisela | Officer | Gen Mgr, Precision Oncology | 2 | 2020 | |
| Lewis-Hall Freda C | Director | 6 | 2020–2023 | ||
| Petrovic Shacey | Director | 9 | 2020–2026 | ||
| Condella Sarah | Officer | EVP, Human Resources; SVP, Human Resources | 44 | 2021–2026 | |
| Clancy Paul J | Director | 9 | 2021–2026 | ||
| Cunningham Everett | Officer | Chief Commercial Officer | 11 | 2021–2024 | |
| Baranick Brian | Officer | EVP, GM, Precision Oncology; EVP, GM., Precision Oncology; Gen. Mgr., Precision Oncology | 24 | 2022–2026 | |
| Herriott James | Officer | General Counsel; SVP, General Counsel & Sec | 24 | 2022–2026 | |
| Scannell Timothy J | Director | 2 | 2023 | ||
| Bloomer Aaron | Officer | EVP, Chief Financial Officer | 6 | 2024–2026 | |
| Barber Michael J | Director | 5 | 2024–2026 | ||
| Popovits Kimberly J | Director | 4 | 2025–2026 | ||
| Trigg Leslie | Director | 4 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Exact Sciences Corporation | WI | State business registries | name and state |
| Business registration | Exact Sciences Corporation | WI | State business registries | name and state |
| Business registration | Exact Sciences Corporation | WI | State business registries | name and state |
| Business registration | Exact Sciences Corporation | WI | State business registries | name and state |
| Business registration | EXACT SCIENCES CORPORATION | WI | State business registries | name and state |
| Business registration | EXACT SCIENCES CORPORATION | WI | State business registries | name and state |
| Business registration | EXACT SCIENCES CORPORATION | WI | State business registries | name and state |
| Business registration | EXACT SCIENCES CORPORATION | WI | State business registries | name and state |
| Business registration | EXACT SCIENCES CORPORATION | WI | State business registries | name and state |
| Federal award recipient | EXACT SCIENCES CORPORATION | WI | Federal spending (USAspending) | name and state |
| Lobbying client | EXACT SCIENCES | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES CORPORATION | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES CORPORATION | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES CORPORATION | WI | Federal lobbying (LDA) | name and state |
| Lobbying client | EXACT SCIENCES CORPORATION | WI | Federal lobbying (LDA) | name and state |
| Paying company | Exact Sciences Corporation | WI | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Exact Sciences Corporation | WI | Patents (USPTO) | name and state |
| SEC filer | EXACT SCIENCES CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Exact Sciences Corporation | WI | Trademarks (USPTO) | name and state |
| Person page | Daniel J Levangie | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | James P Connelly | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Thomas D Carey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.